A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions
- PMID: 22227369
- DOI: 10.1016/j.biocel.2011.12.012
A non-covalent interaction between small ubiquitin-like modifier-1 and Zac1 regulates Zac1 cellular functions
Abstract
Zac1, a zinc-finger protein that regulates apoptosis and cell cycle arrest 1, such as p53, can induce cell-cycle arrest and apoptosis. The transactivation and coactivation functions of Zac1 may occur at non-promyelocytic leukemia nuclear body (PML-NB) sites in the presence of other PML-NB components, including ubiquitin-conjugating 9 (Ubc9). It is unclear whether post-translational modification of Zac1 by the small ubiquitin-like modifier SUMO plays a role in the coactivation functions of Zac1 for the regulation of the p21 gene. Mutagenesis experiments revealed that the two SUMO-binding lysine residues of Zac1, K237 and K424, repress the transactivation activity of Zac1. Studies using a SUMO-1 C-terminal di-glycine motif mutant that is deficient in the ability to form covalent bonds with lysines, SUMO-1 (GA), and a dominant-negative Ubc9 construct (C93S) indicated that SUMO-1 might regulate Zac1 transactivation and coactivation via a non-covalent interaction. Unlike the wild-type Zac1, which induced apoptosis, the Zac1 (K237/424R) double mutant had the ability to induce autophagy. The functional role of p21 remains to be investigated. SUMO-1 selectively suppressed the induction of the p21 gene and protein by wild-type Zac1 but not by the Zac1 (K237/424R) double mutant. Moreover, wild-type Ubc9 but not Ubc9 (C93S) further potentiated the suppression of SUMO-1 in all Zac1-induced p21 promoter activities. Our data reveal that p21 may be an important factor for the prevention of Zac1-induced apoptosis without affecting autophagosome formation. This work indicates that Zac1 functions are regulated, at least in part, via non-covalent interactions with SUMO-1 for the induction of p21, which is important for the modulation of apoptosis.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Modulation of the Zac1's transactivation and coactivation functions via PML and Daxx within distinct subcellular localizations.Int J Biochem Cell Biol. 2010 Jun;42(6):902-10. doi: 10.1016/j.biocel.2010.01.020. Epub 2010 Jan 25. Int J Biochem Cell Biol. 2010. PMID: 20097304
-
Zac1, an Sp1-like protein, regulates human p21(WAF1/Cip1) gene expression in HeLa cells.Exp Cell Res. 2011 Dec 10;317(20):2925-37. doi: 10.1016/j.yexcr.2011.09.018. Epub 2011 Oct 6. Exp Cell Res. 2011. PMID: 22001409
-
Modulation of the cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by Zac1 through the antagonistic regulators p53 and histone deacetylase 1 in HeLa Cells.Mol Cancer Res. 2008 Jul;6(7):1204-14. doi: 10.1158/1541-7786.MCR-08-0123. Mol Cancer Res. 2008. PMID: 18644983
-
Post-translational modification by the small ubiquitin-related modifier SUMO has big effects on transcription factor activity.Curr Opin Genet Dev. 2003 Apr;13(2):108-13. doi: 10.1016/s0959-437x(03)00021-2. Curr Opin Genet Dev. 2003. PMID: 12672486 Review.
-
SUMO Ubc9 enzyme as a viral target.IUBMB Life. 2014 Jan;66(1):27-33. doi: 10.1002/iub.1240. Epub 2014 Jan 6. IUBMB Life. 2014. PMID: 24395713 Review.
Cited by
-
Tissue adaptation to metabolic stress: insights from SUMOylation.Front Endocrinol (Lausanne). 2024 Nov 11;15:1434338. doi: 10.3389/fendo.2024.1434338. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39588331 Free PMC article. Review.
-
Zac1 regulates IL-11 expression in osteoarthritis.Oncotarget. 2018 Aug 21;9(65):32478-32495. doi: 10.18632/oncotarget.25980. eCollection 2018 Aug 21. Oncotarget. 2018. PMID: 30197757 Free PMC article.
-
The regulatory mechanisms of myogenin expression in doxorubicin-treated rat cardiomyocytes.Oncotarget. 2015 Nov 10;6(35):37443-57. doi: 10.18632/oncotarget.5338. Oncotarget. 2015. PMID: 26452256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous